ARTICLE
ejd.2012.1661
Auteur(s) : Óscar Tellechea oetellechea@gmail.com, Mariana
Cravo, Ana Brinca, Margarida Robalo-Cordeiro
Clínica de Dermatologia
Hospital da Universidade de Coimbra
3000-075 Coimbra Portugal
A 35-year-old male presented with atrophic skin lesions on the
back, first noticed 2 months before. Observation showed
asymptomatic, erythematous, slightly atrophic, well circumscribed
small patches, displaying occasional linear or vermiculated
disposition on the middle third of the back (figure 1A).
Some lesions contained minute surface telangiectasias (figure
1B). General physical examination was normal. No
previous treatment had been instituted. Routine blood tests (whole
blood counts, blood chemistry) as well as VIH1 and VIH2, Hepatitis
B and C serologies, ANAs, VDRL, Serum Angiotensin Converting
Enzyme, serum lisozyme and chest X ray were normal or negative.
The histological examination of one lesion disclosed capillary
ectasia in the upper dermis, surrounded by a mild
lymphomononucleated inflammatory infiltrate, flattening of rete
ridges (figure 1E)
and, clearly, PAS positive branching septate hyphae and spores
within the stratum corneum (figure 1F),
featuring the classic «spaghetti and meatballs» aspect,
characteristic of pityriasis versicolor (PV). Verhoeff stain showed
no alterations in the elastic tissue. The diagnosis of PV
atrophicans was then established and the patient was treated with
itraconazole (100 mg/day, 6 weeks) with subsequent resolution
of telangiectasia and major improvement of the atrophy and erythema
(figures
1C-D).
PV atrophicans is an exceptional form of PV [1, 2]. Due to
the misleading aspect of the elementary lesion, the clinical
impression is habitually acne scars or anetoderma/macular atrophy,
as in our case. This may prompt unnecessary investigation of the
multiple causes of secondary macular atrophy.
It is the histological examination that enables the diagnostic
[1]. In fact, although the mycologic study remains important for
diagnosis of PV atrophicans [2], it implies that PV is suspected
clinically, which is seldom the case. Additionally, mycological
evidence of Malassezia on the skin cannot always be equated to PV
[3]. In contrast, histological demonstration of short branching
septate hyphae and spores within the stratum corneum is
characteristic of PV, but not a feature of normal skin, nor of
primary or secondary macular atrophy [4].
PV atrophicans should not be confused with PV pseudoatrophicans
[5, 6]. In the latter, atrophy is iatrogenic and secondary to
prolonged topical corticotherapy. In contrast with PV atrophicans,
in PV pseudoatrophicans the more typical hypo- and hyperpigmentated
PV lesions coexist with the atrophic patches and clinical
resolution requires the suspension of the dermocorticoids.
Although the topography of PV atrophicans generally follows that
of common PV, the face or arm can be exclusively affected [1], or,
as in our case, the middle of the back.
Concerning prognosis, partial or complete resolution can be
expected after appropriate antifungal therapy. This further argues
against the possibility that PV atrophicans could merely represent
anetoderma with incidental Malassezia colonization.
The atrophic and telangiectactic character of PV atrophicans
remain obscure. Capillary ectasia could be related to the direct
angiogenic role of the yeast, or via induction of a Th1
hypersensitivity response to fungal antigens, with release of IFN-γ
and IL-1 [1, 2, 5]. The intensity and the strictly
perivascular disposition of the inflammatory infiltrate, as well as
the absence of eosinophils, as found in our case, would argue in
favour of the latter hypothesis. The atrophy is most probably
related to the flattening of rete ridges, demonstrable in most
cases (figure C), dependent on similar mechanisms [1].
Contrasting to anetoderma, elastic tissue alterations seem
irrelevant to the atrophy in PV atrophicans, as they were not found
in any case, including the present one.
In conclusion, PV atrophicans is an exceptional and clinically
misleading form of PV that should be included in the differential
diagnosis of macular atrophy/anetoderma Histology is diagnostic and
adequate treatment enables the improvement or even the cure of this
curious eruption.
Disclosure
Financial support: none. Conflict of interest:
none
References
1. Crowson AN, Magro CM. Atrophying tinea versicolor: a
clinical and histological study of 12 patients. Int J
Dermatol 2003; 42:928-32.
2. Romano C, Maritati E, Ghilardi A, Miracco C, Mancianti
F. SA case of pityriasis versicolor atrophicans. Mycoses
2005; 48:439-41.
3. Ashbee HR, Evans EG. Immunology of diseases associated
with Malassezia species. Clin Microbiol Reviews 2002 ;15:
21-57.
4. Ackerman AB. Histologic diagnosis of inflammatory
skin diseases. Baltimore. Williams and Wilkins, 1997.
5. Wagner G, Lubach D.Z. Pityriasis versicolor
pseudoatrophicans. Hautkr 1987; 62: 321-24.
6. Mazuecos Blanca J, García-Bravo B, Moreno Giménez JC,
Sotillo I, Camacho F. Pityriasis versicolor pseudoatrofica Med
Cutan Ibero Lat Am 1990; 18:101-03.
|